Manoj’s research, in a process called bioconjugation, involves developing ways to attach a type of molecule called a targeting ligand onto the surface of miniature medicine messengers called nanoparticles.

The link between AI and drug discovery isn’t obvious at first glance. 

We first opened our doors as Pfizer 167 years ago. Since then, every year brings more challenges, more research, and more medicines.